• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2401330 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2024-05-06 Topfond Pharmaceutical Co Ltd view
CYHS2401331 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2024-05-06 Topfond Pharmaceutical Co Ltd view
JYHS2400021 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(5.2) Import Drug Application 2024-04-19 view
JYHS2400020 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(5.2) Import Drug Application 2024-04-19 view
CYHS2303163 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2023-11-18 Zhejiang Nuode Pharmaceutical Co Ltd view
CYHS2303162 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2023-11-18 Zhejiang Nuode Pharmaceutical Co Ltd view
CYHS2303164 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2023-11-18 Zhejiang Nuode Pharmaceutical Co Ltd view
CYHS2300431 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2023-02-11 Jilin Sihuan Pharmaceutical Company Limited view
CYHS2300432 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2023-02-11 Jilin Sihuan Pharmaceutical Company Limited view
CYHS2202021 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2022-11-21 Nanjing Zhengda Tianqing Pharmaceutical Co Ltd view
CYHS2202022 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2022-11-21 Nanjing Zhengda Tianqing Pharmaceutical Co Ltd view
CYHS2200198 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2022-01-26 Jilin Sihuan Pharmaceutical Company Limited view
CYHS2200199 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2022-01-26 Jilin Sihuan Pharmaceutical Company Limited view
JYHB2101610 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs Supplementary Application 2021-12-22 Boehringer Ingelheim International GmbH view
JYHB2101609 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs Supplementary Application 2021-12-22 Boehringer Ingelheim International GmbH view
JYHB2101612 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs Supplementary Application 2021-12-22 Boehringer Ingelheim International GmbH view
JYHB2101611 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs Supplementary Application 2021-12-22 Boehringer Ingelheim International GmbH view
CYHB2101726 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Supplementary Application 2021-08-24 Chengdu Easton Bio Pharmaceuticals Co Ltd view
CYHB2101727 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Supplementary Application 2021-08-24 Chengdu Easton Bio Pharmaceuticals Co Ltd view
CYHS2101373 达比加群酯胶囊 Dabigatran Etexilate Capsule Chemical Drugs(4) Generic Drug 2021-07-01 Zhe JIANG HUA HAI Pharmaceutical Co Ltd view